Clinical Trial Detail

NCT ID NCT01730937
Title Sorafenib Tosylate With or Without Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Radiation Therapy Oncology Group, National Cancer Institute (NCI)
Indications

hepatocellular carcinoma

Therapies

Sorafenib

Age Groups: adult

No variant requirements are available.